Abstract A19: Significantly targeting rituximab resistant B-cell lymphoma (BL) by anti-CD20 chimeric antigen receptor (CAR) modified expanded natural killer (NK) cells.

2013 ◽  
Author(s):  
Yaya Chu ◽  
Janet Ayello ◽  
Ashlin Yahr ◽  
Jared Katz ◽  
Lowrence Lo ◽  
...  
Keyword(s):  
B Cell ◽  
Nk Cells ◽  
Natural Killer ◽  
Chimeric Antigen Receptor ◽  
Cell Lymphoma ◽  
Antigen Receptor ◽  
B Cell Lymphoma ◽  
Anti Cd20

scholarly journals 750. Anti-Tumor Effects of Anti-CD20 Chimeric Antigen Receptor Therapy in Canine B Cell Lymphoma Patients

2016 ◽  
Vol 24 ◽  
pp. S296 ◽  
Author(s):  
M. Kazim Panjwani ◽  
Josephine S. Gnanandarajah ◽  
Martha A. MaloneyHuss ◽  
Nicola J. Mason
Keyword(s):  
B Cell ◽  
Chimeric Antigen Receptor ◽  
Cell Lymphoma ◽  
Antigen Receptor ◽  
B Cell Lymphoma ◽  
Anti Cd20

scholarly journals Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-Alpha

2018 ◽  
Vol 38 (6) ◽  
pp. 239-254 ◽  
Author(s):  
Patricia A. Young ◽  
Reiko E. Yamada ◽  
Kham R. Trinh ◽  
Alex Vasuthasawat ◽  
Satiro De Oliveira ◽  
...  
Keyword(s):  
T Cells ◽  
B Cell ◽  
Interferon Alpha ◽  
Chimeric Antigen Receptor ◽  
Cell Lymphoma ◽  
Antigen Receptor ◽  
B Cell Lymphoma

scholarly journals Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy

2019 ◽  
Vol 25 (11) ◽  
pp. e344-e351 ◽  
Author(s):  
Michael Byrne ◽  
Olalekan O. Oluwole ◽  
Bipin Savani ◽  
Navneet S. Majhail ◽  
Brian T. Hill ◽  
...  
Keyword(s):  
T Cell ◽  
Cell Therapy ◽  
B Cell ◽  
Chimeric Antigen Receptor ◽  
Cell Lymphoma ◽  
Antigen Receptor ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Large B Cell Lymphoma ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document